{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:15:29Z","timestamp":1778505329025,"version":"3.51.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,17]]},"abstract":"<jats:p>RNA N6-methyladenosine (m6A) regulators are essential for a variety of biological functions, such as early development, viral infections, and cancer. However, their roles in Alzheimer disease (AD) are still not very clear. Here, 16 significant m6A regulators were identified using difference analysis between AD patients and non-demented controls based on the GSE132903 dataset from the Gene Expression Omnibus database. Using these 16 m6A regulators, a nomogram model was established to predict the prevalence of AD. We found that patients could obtain a good clinical benefit based on this model. In addition, we revealed 2 distinct m6A patterns and 2 distinct m6A gene patterns in AD and demonstrated their prognostic and risk assessment significance. This present work comprehensively evaluated the functions of m6A regulators in the diagnosis and subtype classification of AD. These results suggested they have potential prognostic and risk assessment significance in AD.<\/jats:p>","DOI":"10.1097\/md.0000000000032945","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T22:42:23Z","timestamp":1676673743000},"page":"e32945","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease"],"prefix":"10.1097","volume":"102","author":[{"given":"Zhiqiang","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyang","family":"Bai","sequence":"additional","affiliation":[{"name":"School of Public Health, China Medical University, Shenyang, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinye","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Beijing Yihua Biotechnology Co., Ltd, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peishen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Beijing Yihua Biotechnology Co., Ltd, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Lv","sequence":"additional","affiliation":[{"name":"Medical Supply Center of Chinese PLA General Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-1931","authenticated-orcid":false,"given":"Yihua","family":"An","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer\u2019s disease facts and figures.","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","article-title":"Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015-2060) in adults aged >\/=65 years.","volume":"15","author":"Matthews","year":"2019","journal-title":"Alzheimers Dement"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer\u2019s disease and down\u2019s syndrome: sharing of a unique cerebrovascular amyloid fibril protein.","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"R5-20250504","first-page":"89","article-title":"Neurofibrillary tangles of Alzheimer\u2019s disease: an immunohistochemical study.","volume":"17","author":"Brion","year":"1985","journal-title":"J Submicrosc Cytol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-170702","article-title":"Role of genetics and epigenetics in the pathogenesis of Alzheimer\u2019s disease and frontotemporal dementia.","volume":"62","author":"Fenoglio","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.3390\/ijms21207571","article-title":"1957 to nowadays: a brief history of epigenetics.","volume":"21","author":"Peixoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","article-title":"The epitranscriptome beyond m(6)A.","volume":"22","author":"Wiener","year":"2021","journal-title":"Nat Rev Genet"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.3390\/ijms23105815","article-title":"Recent advances of m6A demethylases inhibitors and their biological functions in human diseases.","volume":"23","author":"You","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications.","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation.","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-181113","article-title":"Transcriptome changes in the Alzheimer\u2019s disease middle temporal gyrus: importance of RNA metabolism and mitochondria-associated membrane genes.","volume":"70","author":"Piras","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis.","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer.","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-021-03556-6","article-title":"MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration.","volume":"594","author":"Simone","year":"2021","journal-title":"Nature"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"a024539","DOI":"10.1101\/cshperspect.a024539","article-title":"Genetics of beta-amyloid precursor protein in Alzheimer\u2019s disease.","volume":"7","author":"Tcw","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"104785","DOI":"10.1016\/j.nbd.2020.104785","article-title":"Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.","volume":"138","author":"Pimenova","year":"2020","journal-title":"Neurobiol Dis"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"679367","DOI":"10.3389\/fonc.2021.679367","article-title":"m6A modification: a double-edged sword in tumor development.","volume":"11","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","article-title":"mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.","volume":"118","author":"Kumari","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.3390\/ijms21207447","article-title":"An emerging role of m6A in memory: a case for translational priming.","volume":"21","author":"Leonetti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","article-title":"m(6)A enhances the phase separation potential of mRNA.","volume":"571","author":"Ries","year":"2019","journal-title":"Nature"},{"key":"R25-20250504","first-page":"1098285","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/j.cell.2021.03.062","article-title":"Splice site m(6)A methylation prevents binding of U2AF35 to inhibit RNA splicing.","volume":"184","author":"Mendel","year":"2021","journal-title":"Cell"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fnins.2020.00098","article-title":"Abnormality of m6A mRNA methylation is involved in Alzheimer\u2019s disease.","volume":"14","author":"Han","year":"2020","journal-title":"Front Neurosci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"20716","DOI":"10.18632\/aging.203457","article-title":"N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.","volume":"13","author":"Du","year":"2021","journal-title":"Aging (Milano)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"ENEURO.0125","DOI":"10.1523\/ENEURO.0125-20.2020","article-title":"Altered expression of the m6A Methyltransferase METTL3 in Alzheimer\u2019s disease.","volume":"7","author":"Huang","year":"2020","journal-title":"eNeuro"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1240561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma.","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease.","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","article-title":"The role of innate immune genes in Alzheimer\u2019s disease.","volume":"34","author":"Griciuc","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.arr.2017.08.005","article-title":"The role of the immune system in Alzheimer disease: etiology and treatment.","volume":"40","author":"Jevtic","year":"2017","journal-title":"Ageing Res Rev"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imcb.12301","article-title":"The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease.","volume":"98","author":"Webers","year":"2020","journal-title":"Immunol Cell Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:43:53Z","timestamp":1746326633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032945","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}